Crohn's Disease Clinical Trials near Boston, MA
30 studies for Crohn's Disease are recruiting at 41 sites within 50 miles of Boston, Massachusetts, according to ClinicalTrials.gov data processed .
Distances are city-level approximations. See all Crohn's Disease trials in the US or all trials near Boston.
Recruiting now
Crohn's Disease studies enrolling near Boston
- A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
NCT06819878
- Phase 3
- Ages 16 to 80 years
- Sex: All
Nearest sites: Boston University (Boston, MA); Brigham and Women's Hospital (Boston, MA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 3 sites within 50 mi
- An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
NCT07184931
- Phase 3
- Ages 16 to 80 years
- Sex: All
Nearest sites: Tufts Medical Center-Site Number: 8400126 (Boston, MA); UMass Memorial Medical Center-Site Number: 8400121 (Worcester, MA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 3 sites within 50 mi
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
NCT03816345
- Phase 1
- Ages 18 years and older
- Sex: All
Nearest sites: Dana-Farber Cancer Institute (Boston, MA); Massachusetts General Hospital Cancer Center (Boston, MA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- Low Dose IL-2 for the Treatment of Crohn's Disease
NCT04263831
- Phase 1/2
- Ages 12 to 80 years
- Sex: All
Nearest sites: Boston Children's Hospital (Boston, MA); Brigham and Women's Hospital (Boston, MA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
NCT04844606
- Phase 3
- Ages 2 to 19 years
- Sex: All
Nearest sites: Boston Children's Hospital (Boston, MA); Massachusetts General Hospital (Waltham, MA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
NCT05781152
- Phase 4
- Ages 6 to 17 years
- Sex: All
Nearest sites: Boston Children's Hospital (Boston, MA); Rhode Island Hospital (Providence, RI)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
NCT06430801
- Phase 3
- Ages 16 to 80 years
- Sex: All
Nearest sites: Massachusetts General Hospital-Crohn's and Colitis Center ( Site 5037) (Boston, MA); University Gastroenterology - Providence - West River Street ( Site 5057) (Providence, RI)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy
NCT04331639
- Observational
- Ages 5 to 25 years
- Sex: All
Nearest site: Boston Children's Hospital (Boston, MA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease
NCT04508088
- Observational
- Ages 13 to 20 years
- Sex: All
- Accepts healthy volunteers
Nearest site: Boston Children's Hospital (Boston, MA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Personalized Risk Estimation for Crohn's Disease (PRE-Crohn's): Implementation and Feasibility
NCT05332639
- Interventional
- Ages 14 years and older
- Sex: All
- Accepts healthy volunteers
Nearest site: Massachusetts General Hospital (Boston, MA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
NCT05923073
- Phase 3
- Ages 2 to 17 years
- Sex: All
Nearest site: Boston Childrens Hospital (Boston, MA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
NCT06332534
- Phase 3
- Ages 2 to 17 years
- Sex: All
Nearest site: Boston Children's Hospital /ID# 262191 (Boston, MA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Family Members at INcreased-risk for Developing Inflammatory Bowel Disease
NCT06655415
- Observational
- Ages 14 years and older
- Sex: All
- Accepts healthy volunteers
Nearest site: Massachusetts General Hospital (Boston, MA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study to Investigate Efficacy and Safety of Brivekimig in Participants With Crohn's Disease
NCT06958536
- Phase 2
- Ages 18 to 75 years
- Sex: All
Nearest site: Investigational Site Number: 8400022 (Boston, MA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Feasibility of a Wireless Thermal Capsule Endoscopy to Detect Gastrointestinal Thermal Variance
NCT07033208
- Interventional
- Ages 18 to 75 years
- Sex: All
- Accepts healthy volunteers
Nearest site: Massachusetts General Hospital (Boston, MA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study for Imaging the Lower Gastrointestinal Tract Using a Retro-TCE Capsule
NCT07219537
- Interventional
- Ages 18 to 75 years
- Sex: All
- Accepts healthy volunteers
Nearest site: Massachusetts General Hospital (Boston, MA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Zymfentra (Infliximab-dyyb) REal World Cohort STudy
NCT07237516
- Observational
- Ages 18 years and older
- Sex: All
Nearest site: Brigham and Women's Hospital (Boston, MA)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Value of PET/MR Enterography in the Assessment of Crohn's Disease Using a Collagen-binding Radiotracer.
NCT06252493
- Observational
- Ages 18 to 99 years
- Sex: All
Nearest site: Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School (Charlestown, MA)
- Distance to nearest recruiting site
- ~1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
NCT05995353
- Phase 3
- Ages 2 to 17 years
- Sex: All
Nearest site: Massachusetts General Hospital - Mass General Waltham /ID# 255767 (Waltham, MA)
- Distance to nearest recruiting site
- ~9 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
NCT06581328
- Phase 4
- Ages 18 to 80 years
- Sex: All
Nearest sites: Gastro Health Research - Framingham (Framingham, MA); University Gastroenterology (Providence, RI)
- Distance to nearest recruiting site
- ~19 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
NCT06819891
- Phase 3
- Ages 16 to 80 years
- Sex: All
Nearest sites: University of Massachusetts Memorial Medical Center (North Worcester, MA); University Gastroenterology (Providence, RI)
- Distance to nearest recruiting site
- ~39 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
NCT05230173
- Interventional
- Ages 18 years and older
- Sex: All
Nearest site: Gastroenterology Associates (Providence, RI)
- Distance to nearest recruiting site
- ~41 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
NCT06045754
- Phase 4
- Ages 18 to 70 years
- Sex: All
Nearest site: University Gastroenterology (Providence, RI)
- Distance to nearest recruiting site
- ~41 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
NCT06233461
- Phase 2
- Ages 18 to 75 years
- Sex: All
Nearest site: University Gastroenterology Providence (Providence, RI)
- Distance to nearest recruiting site
- ~41 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
NCT06937099
- Phase 3
- Ages 18 to 70 years
- Sex: All
Nearest site: University Gastroenterology (Providence, RI)
- Distance to nearest recruiting site
- ~41 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
NCT07113522
- Phase 2
- Ages 18 to 80 years
- Sex: All
Nearest site: Mirador Therapeutics Selected Site (Providence, RI)
- Distance to nearest recruiting site
- ~41 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
NCT07184944
- Phase 3
- Ages 16 to 80 years
- Sex: All
Nearest site: University Gastroenterology - GI Alliance-Site Number: 8400103 (Providence, RI)
- Distance to nearest recruiting site
- ~41 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
NCT07196722
- Phase 2/3
- Ages 18 years and older
- Sex: All
Nearest site: University Gastroenterology (Providence, RI)
- Distance to nearest recruiting site
- ~41 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- NOV-ERA - A Clinical Trial to Assess the Efficacy and Safety of Ontunisertib Compared to Placebo in Patients With Fibrostenosing Crohn's Disease
NCT07683325
- Phase 2
- Ages 18 years and older
- Sex: All
Nearest site: University Gastroenterology (Providence, RI)
- Distance to nearest recruiting site
- ~41 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
NCT07697456
- Phase 2
- Ages 18 to 75 years
- Sex: All
Nearest site: University Gastroenterology - Providence - Staniford Street /ID# 280919 (Providence, RI)
- Distance to nearest recruiting site
- ~41 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
FAQ
Common questions
What is a clinical trial?
Is there compensation for joining a Crohn's Disease clinical trial?
How do I check if I'm eligible?
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.